Cell Mates
Cell Mates
Podcast Description
Cell Mates is a podcast where we bring together engineers and scientists to tackle the distinct challenges of pharma automation. By combining engineering expertise with scientific insight, we explore how robotics, automation, and AI are advancing the future of pharmaceutical manufacturing. Our mission is to foster collaboration across disciplines and highlight the innovations driving forward the future of the pharmaceutical space.
Podcast Insights
Content Themes
The podcast delves into themes like the integration of robotics in pharma manufacturing, cross-disciplinary innovation, and the impact of AI on personalized therapies, with episodes featuring topics such as misunderstandings between scientists and engineers and the role of automation in enhancing manufacturing scalability.

Cell Mates is a podcast where we bring together engineers and scientists to tackle the distinct challenges of pharma automation.
By combining engineering expertise with scientific insight, we explore how robotics, automation, and AI are advancing the future of pharmaceutical manufacturing.
Our mission is to foster collaboration across disciplines and highlight the innovations driving forward the future of the pharmaceutical space.
What actually makes automation “stick” in cell therapy manufacturing? Is it the tech… or the trust?
In Episode 4 of Cell Mates, Fred sits down with Mary-Ann Santos from Thermo Fisher Scientific to unpack the real adoption flywheel: belief, fear, data, and the moment everything clicks when you see a robot run a process with your own eyes.
They go deep on why modular automation scales faster than “all-in-one” systems, how instrument design can make or break robotics integration, and why the most regulated environments are often the ones where robots shine the brightest (repeatability + sterility, plus, yes, robots don’t breathe).
Highlights include:
- The adoption flywheel: what speeds automation up (and what slows it down)
- Why data beats vibes: building confidence with peer-reviewed performance + demos
- Modular vs all-in-one systems: throughput, bottlenecks, and future-proofing
- “Robot-friendly” instruments: what makes automation easy vs painful
- GMP, sterility, and why humans (lovingly) are a contamination risk
- The next decade: decentralized manufacturing… and what still has to be true for GMP
This episode is about one thing: getting therapies to patients faster without blowing up quality, process trust, or regulatory reality.
New to Cell Mates? We’re the podcast where pharma, robotics, and automation collide to reimagine the future of medicine—one operation at a time.

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.